Clinical Trial Update: Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated the safety, tolerability, pharmacokinetics, and anti-tumor activity of vatalanib in combination with capecitabine in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Vatalanib (vatalanib)

Snippet

Sponsor: Novartis | Conditions: Tumors, Neoplasm Metastasis | Phase 1, Phase 2 | Status: COMPLETED